Home » Merck KGaA MS Pill Rejected by European Drug Agency
Merck KGaA MS Pill Rejected by European Drug Agency
European regulators rejected Merck KGaA’s multiple sclerosis pill cladribine, the second setback in a week for the German drugmaker in the race with Novartis AG for a share of a new market.
Bloomberg
Bloomberg
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May